Top PET/CT centre
in Slovakia
The state-of-the-art diagnostics of oncological, neurological, cardiological and inflammatory diseases. One of the largest PET/CT centres in Slovakia
Our radiopharmaceuticals
are Europe’s top products
BIONT produces Europe’s top radiopharmaceuticals. We are the only producer of radiopharmaceuticals in Slovakia
Previous
Next

Book an appointment

(+421 2 20670 176, 187)

Appointments are made based on a referral completed online or send via post, fax or e‑mail.

Accommodation

Purpose-built accommodation facility is located in a 11‑floor building on Vlárska Street 5/A in Bratislava.

Patient safety

Patient safety is essential for providing high‑quality basic health services.

4 000+

EXAMINATIONS
PER YEAR

52

EXPERTS
ANDSCIENTISTS

7 700+

ANNUAL PRODUCTION
OF RADIOPHARMACEUTICALS

17

YEARS
OF EXPERIENCE

3000+

Vyšetrení ročne

62

odborníkov a vedcov

1200+

ročná produkcia rádiofarmák

17

rokov skúseností

hp-img2
hero-bg

About us.

BIONT, a.s. focuses on the field of nuclear medicine, with a narrower focus on Positron Emission Tomography (PET). Its main mission is to produce and distribute radiopharmaceuticals for logistically accessible PET centres and to provide PET/CT and SPECT/CT examinations for patients from Slovakia and abroad. Closely related to the main activity is the research and development of preparation of radionuclides, radiopharmaceuticals, production equipment and, last but not least, education, training and dissemination of their own know‑how.
More information

Technologies for life.

BIONT is a leading producer of PET radiopharmaceuticals. The company quickly became one of the leading producers of PET radiopharmaceuticals as well as out‑patient healthcare providers in nuclear medicine. As soon as in the first year of its existence, patient examinations using PET/CT and SPECT/CT tomographs began and pilot licensed production of the radiopharmaceutical 18F‑fludeoxyglucose (FDG) was launched with regular deliveries of radiopharmaceuticals to Slovakia and abroad since 2009.
Colorful,X-ray,Scan,Of,Brain
hp-img3

PAPIS

Publicly accessible professional information service

Pharmacovigilance

Reporting adverse drug effects

BiontFDG
and cooperation.

BIONT’s own product – biontFDG radiopharmaceutical – is already registered in six EU countries. Since 2012, it has been manufactured under license by the company Eczacibasi-Monrol in Romania and is currently building new factories in Bulgaria and Poland. In addition to the standard PET/CT examination using FDG, BIONT provides examination using 11C-Methionine and expands its production to include other PET radiopharmaceuticals. BIONT is also a contract manufacturer of FDG for Radiomedic (Czech Republic) and BSM Diagnostica (Austria).